Arrowhead Research reported $417.63M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Anika Therapeutics ANIK:US $ 165.32M 3.21M
Arrowhead Research ARWR:US $ 417.63M 79.35M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Moderna Inc MRNA:US 16.35B 279M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Novartis NOVN:VX 37.24B 8.48B
Opko Health OPK:US $ 754.07M 68.94M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Spectrum Pharmaceuticals SPPI:US $ 93.18M 10.77M
Tg Therapeutics TGTX:US $ 242.22M 88.75M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
Xencor XNCR:US $ 505.97M 81.6M
YTE INCY:US $ 3288.09M 169.42M